This study aimed to compare the relative survival of patients with invasive breast cancer between women from French Guiana (a French territory in South America) and metropolitan France. No study hadever compared survival of breast cancer on the basis of immigrant status in France. Our study underlined that access to care for migrants is challenging whichwgenerates health inequalities.
INTRODUCTION
Breast cancer is the most common type of cancer and the most common cause of cancer-related death in women worldwide. 1 Although breast cancer incidence is much higher in most developed countries than in many developing countries, mortality rates are proportionally higher in less developed regions of the world, notablyin South America. 2, 3 French Guiana is a French territory located on the Guiana shield in South America.Despite a high GDP per capita close to that of France, the incidence of breast cancer in French Guiana is on par with the overall incidence in South America and markedly lower than in France. 4 To reduce the burden of breast cancer and understand differences in cancer prognosis between different areas it is important to identify predictive factors for survival. Stage of disease at diagnosis is the most important prognostic factorforbreast cancer. 5, 6 Overall, early detection, screening and therapeutic improvements havesignificantly reduced breast cancer mortality. [7] [8] [9] Despite this evidence,studies in New Zealand and USAhave shownthat immigrant women were less likely than nonimmigrant women to report having had a mammogram in the past 2 years or to be diagnosed at an early stage of disease. 10, 11 In France, C. Rondet and colleagues, 12 showed that being a foreigner or of immigrant origin was a risk factor for being screened for cancer too late or never and that this gradient persisted after adjusting for socioeconomic characteristics. French Guiana attracts numerous immigrants from South America and the Caribbean who migrate in search of better socioeconomic opportunities. Thus, 30% of the population consists of immigrantsversus8% in metropolitan France. 13 Immigrants have access to health insurance, butin practice this may be somewhat complicated. Particularly, cases requiring specialized care are evacuated towards metropolitan France or Martinique for treatment.Immigrants mayexperience a number of informal barriers to hospital care related to language, unfamiliarity, and cultural factors in a socialised health-care system. 14 It therefore seems important to study survival differences between immigrants and French-born patients.Indeed, in France no study has ever compared breast cancer survival between immigrant and French women. In the present study, we focussed on female breast cancer survival in French Guiana and aimed to determine whether different levels of breast cancer risk between metropolitan France and French Guiana, 4 also implieddifferences in survival. Wedetermined risk factors influencing breast cancer survival in French Guiana taking the immigrant status into account. 15 We estimated that 6 cases of breast cancer were missed between 2003 and 2009: completeness was estimated to be 96%.
MATERIALS AND METHODS

Ethical statement
Prognostic factors
The following socio-demographic factors were studied: age (<35 years [reference group], 35-49 years, 50-64 years, 65-74 years, ≥75 years); place of birth divided in two categories ("France" identifying patients born within all French regions [reference group] and "foreign country" defining patients born outside the Frenchterritory). In addition, information on thetumor were collected by the registry: tumor stage ("localized" T1-3N0M0 [reference group], "regional spread" T1-3N+M0, i.e. axillary lymph nodes that were positive for cancer on histological examination, "local spread" T4NxM0, "distant" M1); we could not distinguish mass screening from selective/opportunistic screening, thus themode of diagnosis was separated in two categories only (screening 
Follow-up
The breast cancer-specificsurvival was estimated byfollowing-up all cases untilDecember 31 st , 2013. The vital status of patients was checked regularly. The follow-up for the vital status can be done actively, through the RNIPP (Repertoire National d'Identification des Personnes Physiques) an emanation of the Insee (Institut national de la statistique et des études économiques), or passively, by matching death certificates at city hall.
Statistical analysis
For cancer cases net survival was the probability of survival in the hypothetical scenario where the studied cancer wasthe only possible cause of death. To compare breast cancer survival between French Guiana and metropolitan France, net survival durations were obtained using the new Pohar-Perme estimator of the net cumulative rate. 16 Age-standardized net survival estimates were calculated using international cancer standard weights. 16, 17 We compared two estimates at a given time with a classical Z-test. Cause-specific survival isanother estimator of net survival. Cox proportional hazard models were used to estimate crude and adjusted mortality hazard ratios to compare breast cancer-specific survival according to prognostic factors. The underlying time scale was the time since diagnosis. The failure event was death due to breast cancer. Sixpatients without follow-up were excluded. No patients were notified with only a death certificate. Associated variables with p-values<0.05 in multivariate analyseswere considered statistically significant. Nonlinearity of continuous variables (age and study period) were assessed using a cubic spline term. 18 The proportional hazards assumption for all the covariates was tested and validated by Schoenfeld residuals. Interactions between variables were also examined and considered if p<0.1 in multivariate analyses.
To avoid loss of information and potentially biased estimates resulting from missing data in Cox analyses, we imputed missing values usingMultivariate Imputation by Chained Equation under missing-at-random (MAR) assumptions. 19 All associated variables with p<0.2 in univariate analyses were also included in the series of chained equations. 20 All data analyses were performed using Stata/MP version 11.1 for Windows (StataCorp, USA).
RESULTS
Between 2003 and 2009, there were 275 new cases of breast cancer. Sixpatients without follow-up were excluded thus 269 patients were included in this study.The median age at diagnosis was 52 years (interquartile range: 44 -60 years), the youngest patient was 27 years old and the oldest was 94 years old. Table 1 presents patient and tumor characteristics. Overall, information on socio-demographic and tumor characteristics were available for 200 (74%) of the patients. Information on age, mode of diagnosis, tumor stage at diagnosis, SBR classification, histological type and hormone receptor status were available for 100%, 89.2%, 88.9%, 82.9%, 92.2% and 83.3% of the patients, respectively. The proportion of patient born outside France was 34.6%. These immigrants originated from Haiti (39%), Brazil (17%), Suriname (13%), Saint Lucia (7%), Guyana (7%), Anguilla (4%), Dominican Republic (3%), China (2%) and others countries (8%). Table 2 shows age-standardized 1, 3, 5-year net survival of invasive breast cancer patients in French Guiana and in metropolitan France. The age-standardized 1-year net survival of women with invasive breast cancer was not significantly different between French Guiana and metropolitan France. The 3-year net survival was 85% in French Guiana, compared to 91% for metropolitan France. This difference was most pronounced five years after the breast cancer diagnosis.The 5-year net survival was 79% in French Guiana versus86% in metropolitan France (p<0.05).Nevertheless, In French Guiana, the overall 5-year net survival rate of foreign-born patients and patients born on the French territory were respectively 62% and 87%. In French Guiana, women born on aFrench territory (including French Guiana) had the same survival rate as in metropolitan France (not shown in the table 2). Table 3 shows the hazard ratio (HR) of death by age, place of birth, mode of diagnosis, study period and tumor characteristics.A total of 65 women (24%) died before the 31 st December 2013 and 60 deaths were attributed to breast cancer. In univariate analyses (complete-cases only)all variables except study period were associated with mortality (p<0.25). In multivariate analyses (after imputation), place of birth, mode of diagnosis, tumor stage at diagnosis, histological type and hormone receptor status remained independently associated with breast cancerspecific survival (p<0.05). After adjusting for these factors, age and SBR classification were no longer associated with specific survival.
DISCUSSION AND CONCLUSIONS
This high resolution study presents survival data of breast cancer patients from French Guiana for the first time. The present study showed that the overall relative survival rate among women with invasive breast cancer in French Guiana was lower than among women in metropolitan France. Regression analysis revealed mode of diagnosis, tumor stage at diagnosis, histological type and hormone receptor status as independent prognostic factors associated with breast cancer-specific survival in French Guiana. The novel result of the present study was that there was a significant difference in breast cancer survival between women in French Guiana according to their immigrant status. Histological type and hormone receptor status are commonly prognostic factors of breast cancer with regard to disease recurrence and survival. 5, 21 The main limitation is that we only had the combined hormone effects on survival. Nevertheless our study showed as in previous studies, 22 that hormone receptor status was an independent prognostic factor of breast cancer survival. Clinical trials have shown that a large proportion of the survival advantage experienced by patients with hormone receptor-positive tumors compared to patients with hormone receptor-negative tumors may be due to the use of hormonal therapy. 22, 23 The mode of diagnosis was consistently associated with mortality among women diagnosed on the basis of clinical symptoms. Since 2004, mass organized screening was initiated throughout the French territory. All women aged 50-74 years are concerned by this every 2 years. As in other studies,the most important feature in the multivariate model was stage at diagnosis. 24, 25 Unsurprisingly, early stage invasive breast cancer hada better prognosis than later stage cancer. Based on ethical and ideological considerations, the mortality of immigrants in France has been scarcely studied. 26 Our study revealeda 1.80-fold difference in HR between women born in France and foreign born women after adjusting for stage at diagnosis and other prognostic factors.Moreover the difference in net survival between French Guiana and metropolitan France could in fact have reflectedthelower net survival rate among foreign-born patients in French Guiana than among patients born on the French territory. Indeed, in French Guiana, women born on the French territory had the same survival rate as in metropolitan France. Previous studies showed that immigrants who experience a language barrier are generally more stressed, which can lead to poorer health overall. 27, 28 There is individual variation in psychosocial environments and McClintock et al., 29 showed that this individual variation could contribute to methylation of cancer genes that are part of the ontogeny of malignant disease throughthe failure of tissue-specific programmed cell death.Moreover,Women of African-ancestry tend to be diagnosedwith more aggressive types of breast cancer, such as ER-(estrogen receptor negative) and ER-/PR-/HER2-(estrogen receptor negative, progesterone receptor negative, HER2 expression negative) breast cancer than populations of European-ancestry. 30 Genome-wide association studies have also identified a few differences in breast cancer risk variants between populations of European and African ancestry. 31, 32 These features should be considered particularly in French Guiana where almost one third of people were born outside France and hadan African-ancestry. One limitation of this paper is that we did not adjust the analyses based on HER2/neu expression becausesuch information was not available for most of the patients from the Registry database. This couldbe the focus of a future article becauseit deserves a thorough evaluation by itself.Another potential study limitation was that hormone receptor status, tumor histology and tumor grade were not assessed centrally becausethe data recorded by the cancer registry of French Guiana were derived from the review of clinical pathology reports from several hospitals. However, the proportions of the different hormone receptor status observed in our study were consistent with those reported in other studies. 33 Many reports suggest less surgery, radiation therapy, and hormone treatment and sometimes inappropriate treatments among African American patients when compared with Caucasian patients. 34 However, since delay of first treatment, type of treatment was unknown for too many women in the present study, this represents another limitation of the results. This could have resulted in some confounders not being accounted for in the model. Despite somelimitations, the present study brings information on survival for clinically different subgroups of cancer patients. Thisimportant information on cancer survivalisof practical interest for health care planners and physicians. Our study underlines that access to care for migrants is challenging and leads tohealth inequalities. This observation comes at a moment when the French Ministry of Health has just released a Health law that places great emphasis on the reduction of health inequalities.Early detection through optimized prevention programs is crucial for increasing breast cancer survival, notably for foreign-born patients who represent a significant proportion of the population in French Guiana. The present results should thus stimulate further research to disentangle the main actionable determinants behind these survival differences.
CLINICAL PRACTICE POINTS
-Some studies showed that being of immigrant origin was a risk factor for being screened for cancer too late or never.
-However, based on ethical and ideological considerations, the mortality of immigrants in France has been scarcely studied.
-Our study showed a statistically significant difference in breast cancer survival between women in French Guiana according to their immigrant status. -The data suggest that physicians and health care plannersshould consider targeting particular vulnerable subgroups of women for appropriate treatment, medical follow-up, and generally for culturally appropriate screening campaigns.
